Search

Displaying results 6201 - 6210 of 10000 in total
  1. Drug

    BTA9881

    go.drugbank.com/drugs/DB05226
    Investigational

    BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.

  2. Drug

    Ty800

    go.drugbank.com/drugs/DB04989
    Investigational

    Ty800 is a vaccine designed to offer rapid, oral, single-dose protection against <i>Salmonella typhi</i>, the cause of typhoid fever. … The Ty800 vaccine was developed using genetic techniques to delete specific genes known to be essential to the virulence of <i>S. typhi</i>. It is being developed by AVANT Immunotherapeutics, Inc.

  3. Drug

    MVA-BN-HER-2

    go.drugbank.com/drugs/DB05733
    Experimental

    Synonyms: MVA-BN-HER-2
  4. Drug

    Istaroxime

    go.drugbank.com/drugs/DB06157
    Investigational

  5. Drug

    Indibulin

    go.drugbank.com/drugs/DB06169
    Investigational

  6. Drug

    Paclitaxel trevatide

    go.drugbank.com/drugs/DB06171
    Investigational

    Three paclitaxel molecules linked by a cleavable succinyl ester linkage to a brain peptide vector, Angiopep-2, conjugate named ANG1005.

    Synonyms: [a-N-(2'succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr
  7. Drug

    Lanimostim

    go.drugbank.com/drugs/DB06559
    Experimental

  8. Drug

    Vipadenant

    go.drugbank.com/drugs/DB06625
    Investigational

  9. Drug

    Zibotentan

    go.drugbank.com/drugs/DB06629
    Investigational

  10. Drug

    Cantuzumab ravtansine

    go.drugbank.com/drugs/DB05594
    Investigational